Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.

BACKGROUND Despite tremendous advancements in the field, our understanding of mild cognitive impairment (MCI) and Alzheimer's disease (AD) among Mexican Americans remains limited. OBJECTIVE The aim of this study was to characterize MCI and dementia among Mexican Americans and non-Hispanic whites. METHODS Baseline data were analyzed from n = 1,705 (n = 890 Mexican American; n = 815 non-Hispanic white) participants enrolled in the Health and Aging Brain Study-Health Disparities (HABS-HD). RESULTS Among Mexican Americans, age (OR = 1.07), depression (OR = 1.09), and MRI-based neurodegeneration (OR = 0.01) were associated with dementia, but none of these factors were associated with MCI. Among non-Hispanic whites, male gender (OR = 0.33), neighborhood deprivation (OR = 1.34), depression (OR = 1.09), and MRI-based neurodegeneration (OR = 0.03) were associated with MCI, while depression (OR = 1.09) and APOEɛ4 genotype (OR = 4.38) were associated with dementia. CONCLUSION Findings from this study revealed that the demographic, clinical, sociocultural and biomarker characteristics of MCI and dementia are different among Mexican Americans as compared to non-Hispanic whites.

[1]  S. O'Bryant,et al.  Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  A. Toga,et al.  Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non‐Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study , 2022, Alzheimer's & dementia.

[3]  A. Toga,et al.  Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer’s Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study , 2021, Dementia and Geriatric Cognitive Disorders.

[4]  A. Toga,et al.  Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: Results from the HABLE study , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[5]  A. Toga,et al.  A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  Sterling C. Johnson,et al.  Association of Neighborhood Context, Cognitive Decline, and Cortical Change in an Unimpaired Cohort , 2021, Neurology.

[7]  S. O'Bryant,et al.  A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials , 2021, Journal of Alzheimer's disease : JAD.

[8]  A. Toga,et al.  The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics , 2021, Alzheimer's & dementia.

[9]  William R. Buckingham,et al.  Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology , 2020, JAMA network open.

[10]  Sterling C. Johnson,et al.  Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume. , 2020, JAMA neurology.

[11]  David T. Jones,et al.  Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. , 2019, JAMA.

[12]  L. Schneider,et al.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need , 2018, Alzheimer's & Dementia.

[13]  Wei Xu,et al.  Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years , 2018, Alzheimer's & Dementia.

[14]  William R. Buckingham,et al.  Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. , 2018, The New England journal of medicine.

[15]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[16]  S. O'Bryant,et al.  Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers , 2018, Developmental neuropsychology.

[17]  P. Montañés,et al.  Estimating Intelligence in Spanish: Regression Equations With the Word Accentuation Test and Demographic Variables in Latin America , 2015, Applied neuropsychology. Adult.

[18]  A. Fagan,et al.  Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research , 2015, Alzheimer's & Dementia.

[19]  D. Royall,et al.  Risk factors for mild cognitive impairment among Mexican Americans , 2013, Alzheimer's & Dementia.

[20]  S. Edland,et al.  Exploratory Study of Apolipoprotein E ε4 Genotype and Risk of Alzheimer's Disease in Mexican Hispanics , 2013, Journal of the American Geriatrics Society.

[21]  S. O'Bryant,et al.  Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[22]  W. Chan,et al.  Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. , 2010, Archives of neurology.

[23]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2010, Neurology.

[24]  Sid E O'Bryant,et al.  Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. , 2008, Archives of neurology.

[25]  Richard W. Bohannon,et al.  Reference Values for the Timed Up and Go Test: A Descriptive Meta‐Analysis , 2006, Journal of geriatric physical therapy.

[26]  D. Mungas,et al.  A Verbal Learning and Memory Test for English- and Spanish-speaking Older Mexican-American Adults , 2002, The Clinical neuropsychologist.

[27]  J. Morris,et al.  Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type , 1997, International Psychogeriatrics.

[28]  Eliseo J. Perez-Stable,et al.  Development of a Short Acculturation Scale for Hispanics , 1987 .

[29]  J. Guralnik,et al.  Short Physical Performance Battery , 2017 .

[30]  Maureen A. Smith,et al.  Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. , 2014, Annals of internal medicine.

[31]  H. Soares,et al.  The link between C-reactive protein and Alzheimer's disease among Mexican Americans. , 2013, Journal of Alzheimer's disease : JAD.